BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors

Published:2010-02-02 Issue:1 Volume:10 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Reithmeier Thomas,Graf Erika,Piroth Tobias,Trippel Michael,Pinsker Marcus O,Nikkhah Guido

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-10-30.pdf

Reference32 articles.

1. Stupp R, Mason WP, Bent van den MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005, 352: 987-996. 10.1056/NEJMoa043330.

2. Wong ET, Hess KR, Gleason MJ, et al: Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol. 1999, 17: 2572-2578.

3. Ammirati M, Galicich JH, Arbit E, et al: Reoperation in the treatment of recurrent intracranial malignant gliomas. Neurosurgery. 1987, 21: 607-614.

4. Choucair AK, Levin VA, Gutin PH, et al: Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. J Neurosurg. 1986, 65: 654-658. 10.3171/jns.1986.65.5.0654.

5. Brandes AA, Fiorentino M: How effective is BCNU in recurrent glioblastoma in the modern era? A phase II trial. Neurology. 2004, 63: 1281-4.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting drug resistance in glioblastoma (Review);International Journal of Oncology;2024-07-09

2. Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches;Medicine;2024-05-24

3. Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with In Silico Drug Repurposing;OMICS: A Journal of Integrative Biology;2024-02-01

4. Current and Future Drugs for Brain Tumors Treatment;Advanced Imaging and Therapy in Neuro-Oncology;2024

5. Effect of gedunin on glioblastoma proliferation and invasiveness:In vitroandin vivoapproaches;2023-06-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3